A part of Watch Media

MedWatchSaturday4 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
11/01/2022at 10:14

European Biomedical Alliance appoints Danish president

The European umbrella organization Biomedical Alliance has brought in Gunhild Waldemar, chair of the Danish Dementia Research Center, as its new president.
Photo: Kim Agersten
by ULRICH QUISTGAARD, translated by daniel pedersen

Danish Gunhild Waldemar starts 2022 with a new job as president for the Biomedical Alliance in Europe, which is an umbrella organization for 36 European medical societies, the group announces in a post on Linkedin.

The Biomedical Alliance in Europe was founded in 2010 to join strengths across a number of different life science areas, unifying a voice to influence decision-makers, industry professionals and the public.

"I am very honored to serve as President of the Biomedical Alliance in Europe 2022-2023 – and to contribute to the advancement of health research on behalf of our member organizations," Waldemar says in a comment to the post.

Waldemar is also the chair of the Danish Dementia Research Center and professor of Clinical Neurology at Danish hospital Righshospitalet. She has been on the board of Biomedical Alliance of Europe since 2016, and she is also a board member of the Lundbeck Foundation.

Big investments in Danish life science industry make 2021 historic year for raising capital

Former Alnylam CEO appointed new chair of Hemab

Former Lundbeck venture advisors start new biotech fund 

Related articles:

  • Photo: Photo: Pexels: Martin Lopez.

    Big investments in Danish life science industry make 2021 historic year for raising capital

    For subscribers

  • Hans Schambye, chairman of Dansk Biotek and CEO of Galecto Biotech | Photo: Henriette Dan Bonde / PR

    Biotech boss overjoyed by new life science fund: "The more the merrier"

    For subscribers

  • Benny Sørensen, CEO of Hemab, is "delighted" to begin the new year by welcoming three new faces to Hemab | Photo: Hemab / PR

    Former Alnylam CEO appointed new chair of Hemab

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix
Medtech

Another hurdle overcome in delaying MDR deadline

EU member countries have voted unanimously to adopt an EU Commission proposal to stagger the implementation of the new Medical Device Regulation. Now, only the EU Parliament’s vote remains. 
  • Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules
  • EU Commission to give more time for MDR transition

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Foto: MedWatch
Other

Top news from MedWatch this week

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology
Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Foto: Coloplast/pr
Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr
Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Further reading

Foto: Tidsvilde Stine/Ritzau Scanpix
Pharma & biotech

Novo Nordisk declared world's best place to work in 2022

The Best Places to Work organization has released its 2022 list of the best workplaces across the world, and Danish Novo Nordisk shines at the top.

For subscribers

Foto: Novo Nordisk / Pr
Pharma & biotech

Novo Nordisk CEO rakes in cash in record year

Being at the top of Denmark’s most valuable company is lucrative, Novo Nordisk reveals in its annual report – and Chief Executive Lars Fruergaard Jørgensen is making a killing there.

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

All Novo Nordisk employees have been offered 37 restricted stock units, which can be turned into real B shares in Aug. 2026.

For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Supply Chain Manager

  • Commercial Director

  • Lead Data Architect

  • Application Manager

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Sr. Director, Drug Safety Physician

  • Clinical Operational Associate

  • Medical Advisor (Metabolism)

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Regulatory Affairs Professional

  • Experienced Patent Counsel

  • Senior Clinical Project Manager

  • Application Manager

See all jobs

Jobs

  • Supply Chain Manager

  • Commercial Director

  • Lead Data Architect

  • Application Manager

  • Senior Health Economics and Outcomes Research (HEOR) Manager

  • Sr. Director, Drug Safety Physician

  • Clinical Operational Associate

  • Medical Advisor (Metabolism)

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Regulatory Affairs Professional

  • Experienced Patent Counsel

  • Senior Clinical Project Manager

  • Application Manager

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge